TrialJournal of the National Cancer Institute2013
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
Michael Gnant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled ittrialcites it